C. Estivill et al. / Tetrahedron 65 (2009) 171–176
175
(400 MHz, CDCl3)
d
9.86 (H11, s, 2H), 8.69 (H1, m, 4H), 7.65 (H2, m, 4H),
1.40 (H14, s, 9H); 13C NMR (100 MHz, CDCl3)
d 162.7 (C11),129.9 (C1a),
129.6 (C9), 127.4 (C2), 125.1 (C1), 58.0 (C13), 22.7 (C14); MS (ES) (m/z,
%): 465 ((MNaþ2)þ,11), 464 ((MNaþ1)þ, 27), 463 (MNaþ,100), 441.1
(MHþ, 6).
3.3. (SS,SS)-N,N0-(1R,10R)-1,10-(Anthracene-9,10-diyl)bis(2,2,2-
trifluoroethane-1,1-diyl)bis(2-methylpropane-2-sulfinamide)
(8RRSSSS)
Under nitrogen 686 mg (1.56 mmol) of (E,E,SS,SS)-N,N0-
(anthracene-9,10-diylbis(methan-1-yl-1-ylidene))bis(2-methylpro
pane-2-sulfinamide) (5SSSS) was dissolved in 30 mL of anhy-
drous THF in
a 250 mL round-bottom flask and 872 mg
(9.36 mmol) of tetramethylammonium fluoride (TMAF) were
added. After cooling at 195 K, 1.85 mL of a freshly prepared
solution of 0.35 M of TMSCF3 in anhydrous THF (12.51 mmol)
was added. After 4 h the reaction was quenched with NH4Cl
solution, raised to room temperature and extracted with AcOEt.
The dried organic phase was evaporated and purified by flash
Figure 11. Aromatic part of HMBC spectrum of compound 1RR at 250 K.
chromatography (hexane/CH2Cl2 70:30), which resulted in
25
796 mg (1.37 mmol, 88%) of 8RRSSSS. Mp dec; [
a
]
254
þ31.0 (c 3,
100
90
80
70
60
50
40
30
20
10
0
H4
CH3OH); IR (KBr) 3267, 2960, 2922, 2851, 1255, 1164, 1096,
H4
1054, 1008, 765, 739 cmꢁ1 1H NMR (500 MHz, CDCl3)
;
d
cisoid
8.5
8.62 (H4, m, 2H), 8.45 (H1, m, 2H), 7.69 (H2, m, 2H), 7.67 (H3, m,
H1
2H), 6.55 (H11, dq, J¼8.31, 2.97 Hz, 2H), 4.14 (NH, d, J¼2.98 Hz,
2H), 1.29 (H17, s, 18H);
d transoid 8.60 (H4, m, 2H), 8.43 (H1, m,
2 +
1RR-D2
8.0
7.5
7.0
6.5
2H), 7.72 (H2, m, 2H), 7.63 (H3, m, 2H), 6.58 (H11, dq, J¼8.58,
3.94 Hz, 2H), 4.22 (NH, d, J¼3.41 Hz, 2H), 1.31 (H17, s, 18H); 13C
NMR (125 MHz CDCl3)
d cisoid 131.5 (C4a), 129.5 (C1a), 128.5–
H2
128.6 (C9), 127.4 (C2), 126.5 (C3), 126.0 (C4), 125.5 (C13
J¼295.6 Hz), 124.4 (C1), 57.0 (C15), 56.1–56.2 (C11, q, J¼32.63 Hz),
22.4 (C17); transoid 129.9 (C4a), 131.1 (C1a), 128.5–128.6 (C9),
, q,
1RR
1RR-D+
d
127.7 (C2), 126.1 (C3), 126.4 (C4), 125.5 (C13, q, J¼295.6 Hz), 123.9
(C1), 57.2 (C15), 56.1–56.2 (C11, q, J¼32.63 Hz), 22.4 (C17); 19F
H11
NMR (235.37 MHz, CDCl3)
d
cisoid ꢁ69.11 (CF3, d, J¼8.6 Hz);
d
transoid ꢁ68.79 (CF3, d, J¼9.5 Hz).
1
3
5
7
9
pH
3.4. (1R,10R)-1,10-(Anthracene-9,10-diyl)bis(2,2,2-
trifluoroethanamine) (1RR)
Figure 12. Evolution of chemical shift of several protons of 1RR with pD (black lines).
Red, blue, and brown lines correspond to the speciation of free amine, monoprotic, and
diprotic ammonium salts, respectively.
In
a 250 mL round-bottom flask 796 mg (1.37 mmol) of
8RRSSSS solved in 60 mL of methanol and 15 mL of HCl (4 M in
1,4-dioxane) was added. After 3.5 h the solution was neutralized
and extracted with AcOEt. The organic phase was dried, concen-
trated, and purified by flash chromatography (hexane/CH2Cl2
0.04
H
COOH
H3C
2
3
0.035
0.03
0.025
0.02
0.015
0.01
0.005
0
85:15) obtaining 354 mg (70%) of the target compound 1RR. Mp
25
114–116 ꢂC; [
a
]
254
ꢁ37.0 (c 3, CH3OH); IR (KBr) 3346, 1255, 1155,
1107, 882, 756 cmꢁ1
9.07 (H4, d, 2H), 8.33 (H1, d, 2H), 7.62 (H2, H3, m, 4H), 6.17 (H11, q,
2H), 2.20 (NH2, s, 4H); transoid 9.14 (H4, m, 2H), 8.35 (H1, m, 2H),
7.62 (H2, H3, m, 4H), 6.22 (H11, q, 2H), 2.20 (NH2, s, 4H); 13C RMN
(125 MHz, CDCl3, 250 K) cisoid 132.1 (C4a), 130.3 (C1a), 130.0 (C9),
128.2 (C4), 127.3 (C2), 127.1 (C13, q, J¼283.7 Hz), 125.9 (C3), 124.2
transoid 131.1 (C4a), 131.3 (C1a),
; d cisoid
1H NMR (500 MHz, CDCl3, 250 K)
d
H2
H3
d
(C1), 53.8 (C11, q, J¼31.7 Hz);
d
129.8 (C9), 128.2 (C4), 127.0 (C2), 127.1 (C13, q, J¼283.7 Hz), 125.9
(C3), 124.5 (C1), 54.1 (C11, q, J¼30.7 Hz); 19F RMN (235.37 MHz,
CDCl3)
d
cisoid ꢁ71.2 (CF3, b),
d
transoid ꢁ71.4 (CF3, b); MS (ES)
(m/z, %): 396 ((MNaþ1)þ, 9), 395 (MNaþ, 43). HRMS (EI, 70 eV):
m/z calcd for C18H14N2F6 [Mþ]: 372.10589; found: 372.10612.
Acknowledgements
0
5
10
eq 1RR/eq ibup.
15
Financial support from CYCYT (BQU2003-01231 and CTQ2006-
´
˜
`
01080) from the Ministerio de Educacion y Ciencia de Espana is
Figure 13. Evolution of enantiodifferentiation of protons H2 and H3 of ibuprofen with
the ratio eq 1RR/eq ibuprofen.
`
gratefully acknowledged. The Servei de Ressonancia Mangnetica